Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Thallion Pharmaceuticals Inc
V.TLN
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:TLN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
box532
X
View Profile
View Bullboard History
Post by
box532
on May 30, 2011 7:51am
Thallion Announces First Patient Enrolled In High
Thallion Pharmaceuticals Inc. TSX : TLN LFB Biotechnologies
...more
(0)
•••
PKParker
X
View Profile
View Bullboard History
Comment by
PKParker
on May 16, 2011 12:59pm
RE: RE: RE: Starting Phase IIb
Thanks DP...sorry if I offended.PK
(0)
•••
PKParker
X
View Profile
View Bullboard History
Comment by
PKParker
on May 16, 2011 12:57pm
RE: E. Coli Superbug on the Verge of Being Untreat
This is very interesting to me.Thing I like about Shigimabs is that the mechanism is very straight forward. This is an anti-toxin and therefore preclinical models should predict efficacy in the clinic
...more
(28)
•••
deadlypup
X
View Profile
View Bullboard History
Comment by
deadlypup
on May 16, 2011 12:13pm
RE: RE: Starting Phase IIb
Sorry PK you’re right. I was just so happy to finally see some news that they were going forward with the drug and got a little excited. Thanks for clarifying the information. You should
...more
(0)
•••
PKParker
X
View Profile
View Bullboard History
Comment by
PKParker
on May 16, 2011 11:48am
RE: Starting Phase IIb
I usually try not to get involved in these discussions, but come on DP lets keep the hype to a minimum. First of all they are not starting a Phase 2b. They are starting the second cohort of a Phase 2a
...more
(28)
•••
deadlypup
X
View Profile
View Bullboard History
Post by
deadlypup
on May 16, 2011 9:02am
Starting Phase IIb
The results from Phase IIa are in and they are good. They are now starting Phase IIb. We should get results by the end of the year. DP
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Post by
thirstytrader
on May 09, 2011 7:11am
E. Coli Superbug on the Verge of Being Untreatable
https://health.msn.com/health-topics/e-coli-superbug-on-the-verge-of-being-untreatable There are hundreds of strains of E. coli bacteria, and most of them are harmless. At the worst, they cause a few
...more
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Comment by
thirstytrader
on Apr 25, 2011 11:13pm
RE: Wild swing today!
Thallion is waiting for the independent committee report in order to know if yes or no they are starting the second cohort of patients... we are supposed to find out in any days now since they said
...more
(1)
•••
ifront
X
View Profile
View Bullboard History
Post by
ifront
on Apr 25, 2011 5:42pm
Wild swing today!
Do you think they have started buying their own stock?Buying back stock is usually a good sign...I am bit dissapointed about the future of TLN. I mean, I thought they would find a cure for something..
...more
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Post by
thirstytrader
on Apr 19, 2011 9:04pm
EX-HEALTH QUEBEC MINISTER IN ON BOARD Waw Phillipp
https://sedar.com/GetFile.do?lang=FR&docClass=13&issuerNo=00028712&fileName=/csfsprod/data116/filings/01708752/00000002/w%3A\Sedar\SEDAR-2011\Thallion\Circular\Voting-results.pdfNominee
...more
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Post by
thirstytrader
on Apr 19, 2011 12:04pm
Ok done with my buyings
Thanks for those 15 cents shares from RBCNow let's wait for the NCIB to start and also the independent revision of the first cohortCheers to the Braves
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Post by
thirstytrader
on Apr 16, 2011 12:45pm
also
the results are very easy to measure, this is not a 4601 trying to reduce a tumor, it's a drug and it's easy to tell if yes or no it works in terms of the E. Coli's presence.a total of 95
...more
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Comment by
thirstytrader
on Apr 16, 2011 12:41pm
RE: RE: retards?
Facts:When have you seen an NCIB on a biotech stock? Which means investing available funds to buy back the stock...They said that they are waiting for an independent review before starting the next
...more
(33)
•••
dreamer05
X
View Profile
View Bullboard History
Comment by
dreamer05
on Apr 16, 2011 12:28pm
RE: retards?
Gio, I agree with you. However what has it got to do with TLN? Perhaps it could also work on other type of bacteria infections. So far it only targets on E. Coli. One thing I notice there is not many
...more
(0)
•••
thirstytrader
X
View Profile
View Bullboard History
Post by
thirstytrader
on Apr 15, 2011 8:34pm
retards?
https://eatocracy.cnn.com/2011/04/15/bacteria-seen-in-nearly-half-of-u-s-meat/
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Scientific Corp. Announces First Quarter 2024 Results
This Small-Cap Gold Stock Jumped Almost 50% on Friday